Our Platform
Approach
Technology
Scientific Materials
Company Materials
LOWE
Pipeline
Who's With Us
Team
Partners
Investors
Investor Relations
ESG
Download Day
Our Story
Story
Mindset
News
Press
Media Kit
Blog
Careers
Our Platform
Approach
Technology
Scientific Materials
Company Materials
LOWE
Pipeline
Who's With Us
Team
Partners
Investors
Investor Relations
ESG
Download Day
Our Story
Story
Mindset
News
Press
Media Kit
Blog
Careers
Characterisation of EXS73565, a Potent and Selective MALT1 Inhibitor with Low Drug-drug Interaction Risk and Potential in Lymphoma
October 23, 2023
Written By:
No items found.
Read the post ›